Skip to main content
TipRanks
Go Ultimate75% OFF

Taki Chemical Co., Ltd. (4025) AI Stock Analysis

0 Followers
JP:4025

Taki Chemical Co., Ltd.

(TSE/TYO:4025)

Select Model
Rating:69Neutral
Price Target:JPY 5,475.00â–²(3.89% Upside)
Action:downgraded
Date:10/23/26

The score is supported primarily by improving profitability and an exceptionally low-leverage balance sheet, which strengthen financial resilience. This is tempered by inconsistent cash-flow generation and currently weak technical momentum (below key short-term moving averages with negative MACD). Valuation is reasonable (P/E 12.64) but the dividend yield is modest (~1.17%).

Positive Factors
Improving ProfitabilityMeaningful margin expansion since 2023 indicates stronger operating economics and improved earnings quality. Higher profitability can provide greater resilience against cost pressure, support reinvestment, and allow more earnings to accumulate over the next several quarters.
Negative Factors
Volatile Cash GenerationUneven free-cash-flow generation weakens the connection between reported earnings and internally available cash. The sharp 2025 reduction could constrain discretionary investment, shareholder distributions, or balance-sheet strengthening if inconsistent conversion persists.

Taki Chemical Co., Ltd. (4025) vs. iShares MSCI Japan ETF (EWJ)

-20%0%20%40%60%80%100%JP:4025+53.22%EWJ+16.06%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 43.99B
Dividend Yield
1.23%
Average Volume (3M)
23.82K
Price to Earnings (P/E)
11.4
Beta (1Y)
0.74
Revenue Growth
8.56%
EPS Growth
38.01%
Country
Japan
Employees
640
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals

Taki Chemical Co., Ltd. Business Overview & Revenue Model

Company Description

Taki Chemical Co., Ltd., founded in 1885 and headquartered in Kakogawa, Japan, is a diversified company operating in the agriculture, chemical, and real estate sectors. Formerly known as Taki Fertilizer Manufacturing Co., Ltd. until its name change i...

How the Company Makes Money

Taki Chemical Co., Ltd. generates revenue primarily by selling chemical products to corporate customers (B2B) under commercial supply agreements. Its earnings are driven by (1) product sales volume and mix across its chemical product lineup, (2) unit...

Taki Chemical Co., Ltd. Financial Statement Overview

Summary

Profitability has improved meaningfully (gross margin ~24.4% and net margin ~7.8% in 2025 vs. ~19.9% and ~3.9% in 2023) and the balance sheet is very conservatively financed (debt-to-equity ~0.03) with growing equity. Offsetting this, cash-flow quality is weaker with volatile free cash flow (negative in 2022–2023 and only ~¥0.75B in 2025) and uneven cash conversion versus net income.

Income Statement

76Positive

Balance Sheet

88Very Positive

Cash Flow

58Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue42.89B41.98B38.92B34.85B35.85B32.81B
Gross Profit10.67B10.24B8.74B6.74B8.61B8.44B
EBITDA4.83B4.53B3.91B2.06B4.03B3.85B
Net Income3.42B3.28B2.30B1.36B2.06B1.92B
Balance Sheet
Total Assets68.41B65.65B58.40B51.30B50.32B46.04B
Cash, Cash Equivalents and Short-Term Investments6.98B7.37B7.46B5.08B6.26B6.53B
Total Debt1.27B1.26B1.22B1.15B1.24B1.34B
Total Liabilities23.02B22.32B20.44B17.40B18.26B16.66B
Stockholders Equity44.94B42.89B37.88B33.82B31.95B29.24B
Cash Flow
Free Cash Flow0748.00M2.53B-529.00M-34.00M218.00M
Operating Cash Flow02.31B4.34B1.62B1.44B2.82B
Investing Cash Flow0-1.06B-1.61B-1.64B-1.08B-2.32B
Financing Cash Flow0-1.46B-352.00M-1.17B-543.00M-498.00M

Taki Chemical Co., Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price5270.00

Price Trends

50DMA5641.20Negative
100DMA5422.20Negative
200DMA4948.90Positive

Market Momentum

MACD-131.28Positive
RSI42.16Neutral
STOCH59.63Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4025, the sentiment is Negative. The current price of 5270.00 is below the 20-day moving average (MA) of 5443.00, below the 50-day MA of 5641.20, and above the 200-day MA of 4948.90, indicating a neutral trend. The MACD of -131.28 indicates Positive momentum. The RSI at 42.16 is Neutral, neither overbought nor oversold. The STOCH value of 59.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4025.

Taki Chemical Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

JP:4025 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:5013JP:501384OutperformJPY 41.31B8.94―3.82%-0.92%0.66%
JP:4463JP:446371OutperformJPY 29.46B7.77―3.46%10.62%52.17%
JP:4025JP:402569NeutralJPY 45.86B11.38―1.23%8.56%38.01%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
JP:4960JP:496059NeutralJPY 8.07B20.98―1.02%6.87%300.65%
JP:4366JP:436648NeutralJPY 14.38B11.80―1.88%10.12%43.23%

* Basic Materials Sector Average

Performance Comparison

0%100%200%300%JP:4025JP:4366JP:4463JP:4960JP:5013Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:4025 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:4025Taki Chemical Co., Ltd.5270.001766.7750.43%
JP:4366Daito Chemix Corporation426.00166.3964.10%
JP:4463Nicca Chemical Co., Ltd.1881.00448.0431.27%
JP:4960Chemipro Kasei Kaisya,Ltd.488.00164.4350.82%
JP:5013Yushiro Chemical Industry Co., Ltd.3195.001014.3946.52%

Taki Chemical Co., Ltd. Corporate Events

Taki Chemical Reports Higher Nine-Month Revenue and Profit

Nov 9, 2026

Taki Chemical Co., Ltd. is a Tokyo-listed chemical company, although the release does not specify its primary products or market focus. For the nine months ended September 30, 2026, revenue rose 9.5% year on year to ¥33.05 billion, while operating pr...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 23, 2026